3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Lung Neoplasms
3
Ovarian Neoplasms
2
Neoplasms
2
Neoplasm, Residual
2
NSCLC
2
Leukemia, Myeloid, Chronic-Phase
2
Kidney Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Thoracic Neoplasms
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Pleural Neoplasms
1
Pleural Effusion, Malignant
1
Pleural Effusion
1
Pleural Diseases
1
Philadelphia Chromosome
1
Neoplasms, Second Primary
1
Neoplasms by Site
1
Lung Diseases
1
Liver Neoplasms
1
Leukemia, Biphenotypic, Acute
1
Leukemia
1
Gastro Intestinal Stromal Tumor
1
Endometrial Neoplasms
1
Congenital Abnormalities
1
Interventions
fludarabine phosphate
73
Peripheral Blood Stem Cell Transplantation
63
Cyclophosphamide
59
Busulfan
51
Tacrolimus
46
Mycophenolic Acid
46
Cytarabine
44
Whole-Body Irradiation
41
Cyclosporine
37
Methotrexate
34
Antilymphocyte Serum
33
Filgrastim
30
Etoposide
29
Radiotherapy
22
Melphalan
21
Flow Cytometry
21
Cord Blood Stem Cell Transplantation
17
Mitoxantrone
14
Methylprednisolone
14
Transplantation
13
Granulocyte Colony-Stimulating Factor
12
Idarubicin
11
Clofarabine
11
sargramostim
10
aldesleukin
10
Thiotepa
9
Polymerase Chain Reaction
9
Alemtuzumab
9
merphos
8
Therapeutics
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Congenital Abnormalities
×
Tyrosine Kinase Inhibitors
×
Clear all
NCT04151342
2025-12-03
CARMA-BROS
University Health Network, Toronto
Recruiting
5,500 enrolled